Zongkai Wu

机构：Hebei Medical University, Hebei General Hospital

发表论文 16 篇 · 总被引 76 次 · h-index 5

代表论文

• Ligustrazine exerts neuroprotective effects via circ_0008146/miR-709/Cx3cr1 axis to inhibit cell apoptosis and inflammation after cerebral ischemia/reperfusion injury (2022 · Brain Research Bulletin · 被引 21)
• Integrated Analysis of Competitive Endogenous RNA Networks in Acute Ischemic Stroke (2022 · Frontiers in Genetics · 被引 15)
• Circulating miRNA‐3552 as a Potential Biomarker for Ischemic Stroke in Rats (2020 · BioMed Research International · 被引 13)
• β-hydroxybutyrate and ischemic stroke: roles and mechanisms (2024 · Molecular Brain · 被引 11)
• The relevance of resveratrol in ameliorating carotid atherosclerosis through glycolysis (2025 · BMC Cardiovascular Disorders · 被引 5)
• Zinc Attenuates Prostate Hyperplasia and Inflammatory Injury in Obese Rats by Regulating Zinc Homeostasis and Inhibiting the JAK1/STAT3 Pathway (2025 · The Prostate · 被引 4)